Predictors of symptomatic intracranial haemorrhage in off-label thrombolysis: an analysis of the Safe Implementation of Treatments in Stroke registry.
Sibu MundiyanapurathK HeesN AhmedN WahlgrenL UhlmannM KieserP A RinglebW HackeSimon NagelPublished in: European journal of neurology (2017)
Thrombolysis appears to be safe with regard to SICH for most of the off-label criteria, especially for minor stroke, but is risky in patients with high blood pressure. Individual risk-benefit evaluation should be performed.